Clinical Factors Associated with Prolonged Cytopenias after CD19 Chimeric Antigen Receptor T-Cell Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia
Regina M. Myers(Children's Hospital of Philadelphia), Michael A. Pulsipher(Primary Children's Hospital), Yimei Li(Children's Hospital of Philadelphia), Samuel John(Southwestern Medical Center), Susan R. Rheingold(Children's Hospital of Philadelphia), Nirali N. Shah(National Institutes of Health), Emily M. Hsieh(Children's Hospital of Los Angeles), Lia Gore(Children's Hospital Colorado), Adam J. Lamble(Seattle Children's Hospital), Amanda M. DiNofia(Children's Hospital of Philadelphia), Jennifer Sheppard(Southwestern Medical Center), Deepa Bhojwani(University of Southern California), Stephan A. Grupp(Children's Hospital of Philadelphia), Rebecca Gardner(Seattle Children's Hospital), Colleen Annesley(Unknown), Hongyan Liu(Children's Hospital of Philadelphia), Lee Chen(Children's Hospital of Philadelphia)
Cited by 2
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k